The role of IL-17 and IL-23 in the pathogenesis of PsO and PsA and their role as therapeutic targets for PsO and PsA treatment. Pub Med Autoimmun Rev, 09/07/2013. (Also see: Psoriasis and Psoriatic Arthritis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.